Skip to main content
SpringerLink
Log in

Silver Sulfadiazine Nanocrystal-Based Hydrogels: The Impact of Lipid Components on In-vitro and Ex-vivo Release, Bacterial Biofilm Permeability, and In-vitro Antibacterial Activity

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

This study developed a new formulation for silver sulfadiazine (SSD) nanocrystal-based hydrogels for in vitro antimicrobial activity.

Methods

SSD nanocrystals were prepared by using a wet-mill apparatus; effects of polymers, surfactants and lipid-based carriers were investigated. The gel-forming chemicals were subsequently dispersed in the SSD nanocrystal nanosuspensions, resulting in homogeneous hydrogels. The antibacterial activities of new formulations were tested in-vitro.

Results

The final SSD nanocrystal formulation (less than 300 nm, PDI: 0.300) containing glyceryl monostearate (GMS) or lecithin (Lec), combining with hydrophilic polymers (hydroxypropyl methyl cellulose and polyvinyl alcohol). The artificial neural network was utilized to confirm the effects of lipid ingredients in wet-milling process. Hydroxyethyl cellulose was chosen to formulate the hydrogel which formed the white, smooth, homogeneous, and stable hydrogel after 4 weeks at the room condition. The hydrogel also presented higher and more sustained drug release using Franz’s diffusion cells as compared with reference marketed drug and control hydrogels. The efficacy of antibacterial activity shown on the biofilm demonstrated effect of particle size, lipid carriers, and probably interaction between SSD with biofilm membrane.

Conclusion

These findings implied a potential application of SSD nanocrystal-lipid carrier-based hydrogels in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatology. 2007;127(3):514–25.

    Article  CAS  Google Scholar 

  2. Miller AC, Rashid RM, Falzon L, Elamin EM, Zehtabchi S. Silver sulfadiazine for the treatment of partial-thickness burns and venous stasis ulcers. J Am Acad Dermatol. 2012;66(5):e159–65.

    Article  CAS  PubMed  Google Scholar 

  3. Hoffmann S. Silver sulfadiazine: an antibacterial agent for topical use in burns. Scand J Plast Reconstr Surg. 1984;18(1):119–26.

    CAS  PubMed  Google Scholar 

  4. Ueda Y, Miyazaki M, Mashima K, Takagi S, Hara S, Kamimura H et al. The effects of silver sulfadiazine on methicillin-resistant Staphylococcus aureus biofilms. 2020;8(10):1551.

  5. Kumar PM, Ghosh A. Development and evaluation of silver sulfadiazine loaded microsponge based gel for partial thickness (second degree) burn wounds. Eur J Pharm Sci. 2017;96:243–54.

    Article  CAS  PubMed  Google Scholar 

  6. Naser NA, Alasedi KM, Khan ZA. New approach for determination of sulfadiazine in pharmaceutical preparations using 4 (4-sulphophenylazo) pyrogallol: kinetic spectrophotometric method. Spectrochim Acta Part A Mol Biomol Spectrosc. 2018;201:267–80.

    Article  CAS  Google Scholar 

  7. Nesbitt RU Jr., Sandmann BJ. Solubility studies of silver sulfadiazine. J Pharm Sci. 1977;66(4):519–22.

    Article  CAS  PubMed  Google Scholar 

  8. Pharmacopoeia J. Japanese Pharmacopoeia 17: Official Monographs Sulfadiazine Silve. 2016.

  9. Costerton JW, Stewart PS, Greenberg EPJ. Bacterial biofilms: a common cause of persistent infections. 1999;284(5418):1318–22.

  10. Jahangir MA, Imam SS, Muheem A, Chettupalli A, Al-Abbasi FA, Nadeem MS, et al. Nanocrystals: characterization overview, applications in drug delivery, and their toxicity concerns. J Pharm Innov. 2022;17(1):237–48.

    Article  Google Scholar 

  11. Venkataraman M, Nagarsenker M. Silver sulfadiazine nanosystems for burn therapy. AAPS PharmSciTech. 2013;14(1):254–64.

    Article  CAS  PubMed  Google Scholar 

  12. Gao L, Gan H, Meng Z, Gu R, Wu Z, Zhu X, et al. Evaluation of genipin-crosslinked chitosan hydrogels as a potential carrier for silver sulfadiazine nanocrystals. Colloid Surf B: Biointerfaces. 2016;148:343–53.

    Article  CAS  PubMed  Google Scholar 

  13. Liu X, Gan H, Hu C, Sun W, Zhu X, Meng Z et al. Silver sulfadiazine nanosuspension-loaded thermosensitive hydrogel as a topical antibacterial agent. Int J Nanomed. 2019:289–300.

  14. Mastiholimath VS, Valerie CTW, Shrishailappa V, Mannur PMD, Gadad AP, Khanal P. Formulation and evaluation of solid lipid nanoparticle containing silver sulfadiazine for second and third degree burn wounds and its suitable analytical method development and validation. Indian J Pharm Educ Res. 2020;54:31–45.

    Article  CAS  Google Scholar 

  15. Malamatari M, Taylor KM, Malamataris S, Douroumis D, Kachrimanis K. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discovery Today. 2018;23(3):534–47.

    Article  CAS  PubMed  Google Scholar 

  16. Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62(11):1569–79.

    Article  CAS  PubMed  Google Scholar 

  17. Nguyen TK, Peyrusson F, Siala W, Pham NH, Nguyen HA, Tulkens PM, et al. Activity of Moxifloxacin Against Biofilms formed by clinical isolates of Staphylococcus aureus Differing by their resistant or Persister Character to fluoroquinolones. Front Microbiol. 2021;12:785573.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Tuomela A, Hirvonen J, Peltonen LJP. Stabilizing agents for drug nanocrystals: effect on bioavailability. 2016;8(2):16.

  19. Sargam Y, Wang K, Tsyrenova A, Liu F, Jiang S. Effects of anionic and nonionic surfactants on the dispersion and stability of nanoSiO2 in aqueous and cement pore solutions. Cem Concr Res. 2021;144:106417.

    Article  CAS  Google Scholar 

  20. Attama AA, Momoh MA, Builders PF. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development. Recent Adv Novel drug Carrier Syst. 2012;5:107–40.

    Google Scholar 

  21. Tran BN, Tran HT, Le GT, Tran HP, Le KN, Do HH et al. Solidifying Fenofibrate Nanocrystal Suspension: A Scalable Approach via Granulation Method. 2023;2023.

  22. Tran BN, Nguyen HT, Kim JO, Yong CS, Nguyen, CNJAopr. Combination of a chemopreventive agent and paclitaxel in CD44-targeted hybrid nanoparticles for breast cancer treatment. 2017;40:1420–32.

  23. Bult A, Plug CM. Silver sulfadiazine. Analytical profiles of Drug Substances. Volume 13. Elsevier; 1984. pp. 553–71.

  24. Sheskey PJHB, Moss GP, Goldfarb DJ. Handbook of pharmaceutical excipients: Edition 9. Pharmaceutical; 2020.

  25. Iwai I, Han H, Hollander Ld, Svensson S, Öfverstedt L-G, Anwar J, et al. The human skin barrier is Organized as stacked bilayers of fully extended ceramides with Cholesterol Molecules Associated with the Ceramide Sphingoid Moiety. J Invest Dermatology. 2012;132(9):2215–25.

    Article  CAS  Google Scholar 

  26. Dannert C, Stokke BT, Dias RS. Nanoparticle-hydrogel composites: from molecular interactions to macroscopic behavior. 2019;11(2):275.

  27. Tran BN, Tran KL, Nguyen TT, Bui LT, Nguyen CN. A Novel Alginate Film based on Nanocoating Approach for enteric-release tablets. AAPS PharmSciTech. 2023;24(4):99.

    Article  CAS  PubMed  Google Scholar 

  28. Nguyen TK, Argudín MA, Deplano A, Nhung PH, Nguyen HA, Tulkens PM et al. Antibiotic resistance, biofilm formation, and intracellular survival as possible determinants of persistent or recurrent infections by staphylococcus aureus in a Vietnamese tertiary hospital: focus on bacterial response to moxifloxacin. 2020;26(6):537–44.

  29. Siala W, Kucharíková S, Braem A, Vleugels J, Tulkens PM, Mingeot-Leclercq M-P, et al. The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase. Nat Commun. 2016;7(1):13286.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cerca N, Pier GB, Vilanova M, Oliveira R, Azeredo, JJRim. Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis. 2005;156(4):506–14.

  31. Mizdal CR, Stefanello ST, da Costa Flores V, Agertt VA, Bonez PC, Rossi GG et al. The antibacterial and anti-biofilm activity of gold-complexed sulfonamides against methicillin-resistant Staphylococcus aureus. 2018;123:440–8.

  32. Vaze N, Demokritou P. Using engineered water nanostructures (EWNS) for wound disinfection: case study of Acinetobacter baumannii inactivation on skin and the inhibition of biofilm formation. Nanomed Nanotechnol Biol Med. 2022;42:102537.

    Article  CAS  Google Scholar 

  33. Siqueira FS, Alves CFS, Machado AK, Siqueira JD, Santos Td, Mizdal CR et al. Molecular docking, quorum quenching effect, antibiofilm activity and safety profile of silver-complexed sulfonamide on Pseudomonas aeruginosa. 2021;37(5):555–71.

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Pharmacy and Medical Equipment, National Burn Hospital, Hanoi, Vietnam

    Anh Quang Luong

  2. Educational Institute of Pharmacy, Vietnam Military Medical University, Hanoi, Vietnam

    Anh Quang Luong

  3. Faculty of Pharmaceutics and Pharmaceutical Technology, Hanoi University of Pharmacy, Hanoi, Vietnam

    Hien Thanh-Thi Pham, Bao Ngoc Tran & Chien Ngoc Nguyen

  4. Faculty of Biotechnology, Hanoi University of Pharmacy, 13-15 Le Thanh Tong Street, Hoan Kiem district, Hanoi, Vietnam

    Tiep Khac Nguyen

  5. National Institute of Pharmaceutical Technology, Hanoi University of Pharmacy, 13-15 Le Thanh Tong Street, Hoan Kiem district, Hanoi, Vietnam

    Chien Ngoc Nguyen

Authors
  1. Anh Quang Luong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hien Thanh-Thi Pham
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bao Ngoc Tran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tiep Khac Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chien Ngoc Nguyen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Tiep Khac Nguyen or Chien Ngoc Nguyen.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical Approval

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luong, A.Q., Pham, H.TT., Tran, B.N. et al. Silver Sulfadiazine Nanocrystal-Based Hydrogels: The Impact of Lipid Components on In-vitro and Ex-vivo Release, Bacterial Biofilm Permeability, and In-vitro Antibacterial Activity. J Pharm Innov 19, 24 (2024). https://doi.org/10.1007/s12247-024-09834-w

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12247-024-09834-w

Keywords

Search

Navigation